scholarly article | Q13442814 |
P356 | DOI | 10.1164/RCCM.201606-1143OC |
P698 | PubMed publication ID | 28146645 |
P50 | author | Karin Tarte | Q47108950 |
Fabrice Uhel | Q50741537 | ||
Thierry Fest | Q56997299 | ||
Mikael Roussel | Q57070336 | ||
Céline Pangault | Q59609247 | ||
Luc Cynober | Q110577542 | ||
P2093 | author name string | Arnaud Gacouin | |
Christophe Camus | |||
Imane Azzaoui | |||
Jean-Marc Tadié | |||
Yves Le Tulzo | |||
Joelle Dulong | |||
Murielle Grégoire | |||
P2860 | cites work | Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock | Q44803821 |
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses | Q45020410 | ||
Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation | Q45408186 | ||
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation | Q45750460 | ||
Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet--a pharmacokinetic randomized controlled study | Q46180037 | ||
Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience. | Q50741452 | ||
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. | Q51241980 | ||
Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients. | Q53160619 | ||
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration* | Q57219590 | ||
Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
Neutrophil granules and secretory vesicles in inflammation | Q28183749 | ||
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 | ||
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice | Q33721765 | ||
Myeloid-derived suppressor cells in sepsis | Q33786718 | ||
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer | Q33897765 | ||
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes | Q33978763 | ||
Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism | Q34081723 | ||
Nomenclature of monocytes and dendritic cells in blood. | Q34125860 | ||
Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection | Q34477577 | ||
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients | Q34599210 | ||
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients | Q34667638 | ||
A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma | Q34699543 | ||
Persistent lymphopenia after diagnosis of sepsis predicts mortality. | Q35184876 | ||
Complexity and challenges in defining myeloid-derived suppressor cells | Q35509317 | ||
Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response | Q36018144 | ||
Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis | Q36625054 | ||
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis | Q37287072 | ||
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis | Q37360321 | ||
Refining the white blood cell differential: the first flow cytometry routine application | Q37761122 | ||
The function of neutrophils in sepsis | Q37994057 | ||
The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? | Q38086392 | ||
Myeloid-derived suppressor cell heterogeneity in human cancers | Q38223250 | ||
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis | Q38438969 | ||
Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. | Q38916509 | ||
Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock | Q39779016 | ||
Long-Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population-based Study. | Q40063876 | ||
A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission | Q41134628 | ||
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. | Q41413026 | ||
A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases | Q42210487 | ||
Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome | Q42519810 | ||
Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. | Q43164002 | ||
Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity | Q43722700 | ||
Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis | Q44246026 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
hospital-acquired infection | Q215509 | ||
P304 | page(s) | 315-327 | |
P577 | publication date | 2017-02-01 | |
P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
P1476 | title | Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis | |
P478 | volume | 196 |
Q47310265 | Advances in the understanding and treatment of sepsis-induced immunosuppression. |
Q64941408 | Alleviation of exhaustion-induced immunosuppression and sepsis by immune checkpoint blockers sequentially administered with antibiotics-analysis of a new mathematical model. |
Q42696537 | Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers |
Q91923409 | Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity |
Q94948589 | Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells |
Q90828848 | Current gaps in sepsis immunology: new opportunities for translational research |
Q90707412 | Damage-associated molecular patterns in trauma |
Q55355541 | Danger signals in trauma. |
Q92132610 | Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome |
Q38652940 | Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients |
Q90436066 | Dynamic LTR retrotransposon transcriptome landscape in septic shock patients |
Q91638947 | Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics |
Q91770596 | Expanding Neutrophil Horizons: New Concepts in Inflammation |
Q92031701 | Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis |
Q46302385 | Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period. |
Q92469045 | How Clinical Flow Cytometry Rebooted Sepsis Immunology |
Q90101108 | Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting |
Q42709152 | Improving Prediction Accuracy of "Central Line-Associated Blood Stream Infections" Using Data Mining Models. |
Q52579155 | Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy. |
Q90559897 | Innate T cells in the intensive care unit |
Q88691581 | Integrative Physiology of Pneumonia |
Q64094878 | Myeloid-Derived Suppressor Cells in Sepsis |
Q48215791 | Myeloid-derived suppressor cells coming of age. |
Q64889881 | Neutrophil heterogeneity and its role in infectious complications after severe trauma. |
Q64911836 | Neutrophil-mediated T-Cell Suppression in Influenza: Novel Finding Raising Additional Questions. |
Q47563950 | Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells |
Q87870528 | Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study |
Q58072342 | Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery |
Q52725174 | S100A8/A9 Drives Neuroinflammatory Priming and Protects against Anxiety-like Behavior after Sepsis. |
Q95271890 | Sepsis Triggers a Late Expansion of Functionally Impaired Tissue-Vascular Inflammatory Monocytes During Clinical Recovery |
Q59136322 | Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation |
Q59800492 | Sepsis-Induced Immunosuppression in Neonates |
Q98563108 | Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment |
Q64079211 | The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study |
Q57818269 | Update on Neutrophil Function in Severe Inflammation |
Search more.